CFDE Data Portal | Search GPAA1

	Label	Description
	GPAA1 Gene (Entity type)	ENSG00000197858 - glycosylphosphatidylinositol anchor attachment 1
	GPAA1 associations Collection (Entity type)	Associations for GPAA1_associations
	GPAA1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GPAA1 HUMAN Protein (Entity type)	Glycosylphosphatidylinositol anchor attachment 1 protein
	GPAA1 MOUSE Protein (Entity type)	Glycosylphosphatidylinositol anchor attachment 1 protein
	GSE216043 7 V 9 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE229973 3 V 2 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE238213 dopamine 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE95077 1 V 2 AMILORIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE228430 FABP5 inhibition Huh-7 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS

GPAA1

ENSG00000197858 - glycosylphosphatidylinositol anchor attachment 1

GPAA1 associations

Associations for GPAA1_associations

GPAA1 associations.tsv

A file from IDG as part of the Harmonizome project

GPAA1 HUMAN

Glycosylphosphatidylinositol anchor attachment 1 protein

GPAA1 MOUSE

Glycosylphosphatidylinositol anchor attachment 1 protein

GSE216043 7 V 9 CISPLATIN HUMAN DN

A Gene Set from LINCS

GSE229973 3 V 2 CISPLATIN HUMAN DN

A Gene Set from LINCS

GSE238213 dopamine 1 v 0 human dn

A Gene Set from LINCS

GSE95077 1 V 2 AMILORIDE HUMAN DN

A Gene Set from LINCS

GSE228430 FABP5 inhibition Huh-7 2 v 0 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.